The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis; Ono Pharmaceutical
Confirmatory trial of narrower side margin excision for head and neck basal cell carcinoma in the Japanese (East Asian) population: JCOG2005 (J-BASE-MARGIN).
 
Yasuhiro Nakamura
Honoraria - Bristol-Myers Squibb Japan; Kyowa Kirin International; Maruho; Mitsubishi Tanabe Pharma; MSD Oncology; Novartis Pharmaceuticals UK Ltd.; Ono Pharmaceutical; Taiho Pharmaceutical; Taisho Toyama Pharma
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.
Research Funding - Kaken Pharmaceutical (Inst); Ono Pharmaceutical (Inst); Pola Pharma (Inst); Torii Pharmaceutical (Inst)
 
Yusuke Sano
No Relationships to Disclose
 
Tomoko Kataoka
No Relationships to Disclose
 
Taro Shibata
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma
 
Shigeto Matsushita
Honoraria - Bristol-Myers Squibb Japan; Kyowa Kirin; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Novartis
 
Yasuhiro Fujisawa
Consulting or Advisory Role - Lilly; Novartis
Speakers' Bureau - Novartis; Ono Pharmaceutical
Research Funding - Eisai; Ono Pharmaceutical
 
Tatsuya Takenouchi
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD Oncology; Novartis; Ono Pharmaceutical
 
Toshikazu Omodaka
No Relationships to Disclose
 
Kentaro Yamamura
No Relationships to Disclose
 
Megumi Aoki
No Relationships to Disclose
 
Hiroshi Uchi
Honoraria - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical
 
Keita Tsutsui
No Relationships to Disclose
 
Shusuke Yoshikawa
No Relationships to Disclose
 
Dai Ogata
No Relationships to Disclose
 
Hiroto Yanagisawa
No Relationships to Disclose
 
Jun Omatsu
No Relationships to Disclose
 
Takamichi Ito
No Relationships to Disclose
 
Kenjiro Namikawa
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
Consulting or Advisory Role - Novartis
Research Funding - Ono Pharmaceutical (Inst)
 
Naoya Yamazaki
Consulting or Advisory Role - Chugai Pharma; MSD; Ono Pharmaceutical
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Novartis; Ono Pharmaceutical
Research Funding - Astellas Amgen BioPharama (Inst); Bristol-Myers Squibb Japan (Inst); Merck Serono (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Takara Bio (Inst)